Research Programmes being run in the Department
Clinical validation of a CYP2B6 pharmacogenetics test based dosing algorithm in the safe and efficacious use of efavirenz in a public health care setting (AIBST-UZCHS GRACE Programme) DPhil
Drug-drug interaction in the co-administration of the antiretroviral drugs and the antischistosomide praziquantel(AIBST-UZCHS GRACE Programme) DPhil
Comparison of individualized and standard care for antiviral drug therapy through implementing pharmacogenetics diagnostics(AIBST-UZCHS GRACE Programme) DPhil
Anti-cancer efficacy of selected herbal plants commonly used to treat cancer in Zimbabwe DPhil
The effect of genetic polymorphisms on cervical cancer patients under chemoradiotherapy treatment in Harare, Zimbabwe DPhil
The effects of African potato (hypoxis hemerocallidea) on the pharmacokinetics of tenofovir and lamivudine DPhil
Genetic basis of validity of warfarin exposure responses in African populations – a pharmacogenetics approach DPhil
Pharmacokinetics and pharmacogenetics of tamoxifen in healthy volunteers: effect of the CYP2D6*17 on the plasma levels of tamoxifen and its metabolites(AIBST-UZCHS GRACE Programe) MPhil
Praziquantel metabolism and molecular modeling to address rapid first pass metabolism in the development of a paediatric formulation of praziquantel in the treatment of schistosomiasis(AIBST-UZCHS GRACE Programe)
HIV-1 Genetic diversity and natural polymorphisms of the integrase gene in integrase inhibitor naïve patients in Zimbabwe MPhil